2021
DOI: 10.3390/v13102008
|View full text |Cite
|
Sign up to set email alerts
|

Role of Serum Vitamin D, Interleukin 13, and microRNA-135a in Hepatocellular Carcinoma and Treatment Failure in Egyptian HCV-Infected Patients Receiving Direct Antiviral Agents

Abstract: Direct-acting antivirals (DAAs) are used for hepatitis C virus (HCV) treatment. However, treatment failure and hepatocellular carcinoma (HCC) development following treatment was reported. In this study, we assessed the role of serum vitamin D, interleukin 13 (IL-13), and microRNA-135a in the prediction of treatment failure with DAA and HCC development among Egyptian HCV-infected patients. A total of 950 patients with HCV-related chronic liver disease underwent DAA treatment. Before DAAs, serum vitamin D and IL… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2
2

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 109 publications
(121 reference statements)
0
2
0
Order By: Relevance
“…A meta-analysis concluded by Hu et al represent that CHB patients display lower vitamin D levels compared to healthy individuals, with lower vitamin D status being more frequent in patients with high viral load. Other studies suggest vitamin D as a marker for HCC development (18,26).…”
Section: Vitamin D and Viral Loadmentioning
confidence: 99%
“…A meta-analysis concluded by Hu et al represent that CHB patients display lower vitamin D levels compared to healthy individuals, with lower vitamin D status being more frequent in patients with high viral load. Other studies suggest vitamin D as a marker for HCC development (18,26).…”
Section: Vitamin D and Viral Loadmentioning
confidence: 99%
“…Moreover, numerous challenges still remain in HCV treatment, such as barriers to screening, linkage to care, access to medication, and high pharmaceutical costs. In a study conducted on Egyptian HCV-infected patients receiving DAAs, a direct association was shown between prognostic markers such as interlukin-13, vitamin D, and the expression of miR-135a with treatment failure and hepatocellular carcinoma (HCC) development (Ali et al) [ 7 ].…”
mentioning
confidence: 99%